Korten Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 3.00 Cr
as on 05-07-2024
- Company Age 34 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.40 Cr
as on 05-07-2024
- Satisfied Charges ₹ 50.42 Cr
as on 05-07-2024
- Revenue 4.97%
(FY 2022)
- Profit 87.10%
(FY 2022)
- Ebitda 33.83%
(FY 2022)
- Net Worth 11.28%
(FY 2022)
- Total Assets 30.06%
(FY 2022)
About Korten Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹1.40 Cr. The company has closed loans amounting to ₹50.42 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rahul Jain, Pravin Jain, and Uttamchand Jain serve as directors at the Company.
- CIN/LLPIN
U24239MH1990PTC058797
- Company No.
058797
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 1990
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Korten Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Jain  | Director | 05-Jan-2013 | Current |
| Pravin Jain | Director | 15-Feb-2014 | Current |
| Uttamchand Jain | Director | 05-Jan-2013 | Current |
Financial Performance and Corporate Structure Insights of Korten Pharmaceuticals.
Korten Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.97% increase. The company also saw a substantial improvement in profitability, with a 87.1% increase in profit. The company's net worth Soared by an impressive increase of 11.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Korten Pharmaceuticals?
In 2022, Korten Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uttaranchal Biotech LimitedActive 19 years 3 monthsRahul Jain, Pravin Jain and 1 more are mutual person
Surajlok Chemicals Private LimitedActive 33 years 10 monthsRahul Jain and Pravin Jain are mutual person
Vhb Medi Sciences LimitedActive 17 years 3 monthsRahul Jain, Pravin Jain and 1 more are mutual person
- Vhb Life Sciences LimitedActive 17 years 6 months
Rahul Jain, Pravin Jain and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 05 Feb 1996 | ₹5.00 M | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 05 Feb 1996 | ₹5.00 M | Open |
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 02 Nov 1994 | ₹4.00 M | Open |
How Many Employees Work at Korten Pharmaceuticals?
Korten Pharmaceuticals has a workforce of 176 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Korten Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Korten Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
